Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.59 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.57 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.57 |
| ▸ | TFPI | P10646 | 4/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.56 |
| ▸ | KDM1A | O60341 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | KDM5A | P29375 | 1/20 | 0.54 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22077026 | 1.00 | CALCR (0.59) | CALCRCRHR1CRHR2TFPIKEAP1 | |
| SCHEMBL30495646 | 0.89 | CALCR (0.65) | CALCRCRHR1CRHR2TFPI | |
| SCHEMBL31332191 | 0.89 | F2 (0.58) | CALCRCRHR1CRHR2KEAP1 | |
| SCHEMBL30432528 | 0.88 | CALCR (0.68) | CALCRCRHR1CRHR2TFPIKEAP1 | |
| SCHEMBL30186415 | 0.87 | CALCR (0.56) | CALCRCRHR1CRHR2TFPI | |
| SCHEMBL31031539 | 0.87 | CALCR (0.63) | CALCRCRHR1CRHR2TFPIKEAP1 | |
| SCHEMBL11652679 | 0.86 | CALCR (0.65) | CALCRCRHR1CRHR2 | |
| SCHEMBL11651841 | 0.86 | CALCR (0.65) | CALCRCRHR1CRHR2 | |
| SCHEMBL11667794 | 0.86 | CALCR (0.64) | CALCRCRHR1CRHR2TFPI | |
| SCHEMBL30883253 | 0.86 | CALCR (0.63) | CALCRTFPIKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10456439-B2 | NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation | ACADEMISCH MEDISCH CENTRUM (NL) | 2019-10-29 | — | — | US | disclosed |
| US-20190015471-A1 | NK3 AGONIST FOR USE IN THE TREATMENT OF A PATIENT SUFFERING FROM ATRIAL ARRHYTHMIA OR FIBRILLATION | Stichting Amsterdam UMC (NL) | 2019-01-17 | — | — | US | disclosed |